Tempur is conducting extensive textile testing and evaluations at its Sealy R&D facility in Trinity, N.C.
By Alan Wolf, YSN
Tempur Sealy plans to employ an antimicrobial and antiviral technology to select Sealy, Tempur-Pedic and Stearns & Foster mattresses in 2021.
The company claims its new Surface-Guard Technology kills 99 percent of bacteria on mattresses and is at least 99 percent effective at killing viruses, including human coronavirus, within five minutes. The process is registered with the Environmental Protection Agency (EPA) and Tempur is presently seeking approval for its antiviral claims from the U.S. Food & Drug Administration (FDA) and the EPA.
In a statement, Tempur chairman, president and CEO Scott Thompson said the introduction of Surface-Guard Technology “represents the latest in a long line of innovations,” citing the company’s more than 10-year history of antimicrobial and anti-allergen treatments. “Our planned introduction of this cutting-edge technology will help keep our mattresses clean and safe and will be yet another reason for consumers to turn to Tempur Sealy products for their best night’s sleep.”
Within the Sealy portfolio, the enhanced mattress protection will be available across the Sealy Posturepedic and Sealy Posturepedic Plus lines in early 2021, the company said, with Tempur-Pedic and Stearns & Foster products to follow later in the year.
Tempur’s announcement of its Surface-Guard technology follows word from Serta Simmons in July of a patented Viroblock fabric treatment that can reportedly kill the COVID-19 virus. No launch date for Viroblock-infused Serta, Beautyrest or Tuft & Needle mattresses has been announced.